Bank of Montreal, Canada: Maintaining the AbbVie (ABBV.US) rating, adjusted from superior to superior market rating, target price adjusted from $195.00 to $180.00.
Bank of Montreal, Canada: Maintaining the AbbVie (ABBV.US) rating, adjusted from superior to superior market rating, target price adjusted from $195.00 to $180.00.
Why SaaS Company Conduent's Shares Are Rising Today
Shares of digital platform services provider Conduent Inc (NASDAQ:CNDT) are trading higher after the company announced a collaboration with tech giant Microsoft Corp (NASDAQ:MSFT).Conduent will use Mi
BMO Capital Maintains Outperform on AbbVie, Lowers Price Target to $180
BMO Capital analyst Evan David Seigerman maintains AbbVie (NYSE:ABBV) with a Outperform and lowers the price target from $195 to $180.
AbbVie Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 11.93% BMO Capital $195 → $180 Maintains Outperform 03/27/2024 21.26% Barclays $185 → $195 Main
Amazon Earnings Are Coming. Could a Dividend Announcement Be Part of the Mix?
Is Tesla FSD coming to China soon? The official purchase page says it will be available soon
Tesla China's official response: The estimate is fast; it's hard to say the exact time.